Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
405.9 BRL | -0.21% |
|
-.--% | +9.48% |
06-13 | DuPont Launches New Tedlar® Frontsheet Offerings At 2024 Snec Pv Power Expo | CI |
06-07 | Declaration of Voting Results by DuPont de Nemours, Inc | CI |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- For the past twelve months, EPS forecast has been revised upwards.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Analyst opinion has improved significantly over the past four months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company benefits from high valuations in earnings multiples.
- With an enterprise value anticipated at 3.18 times the sales for the current fiscal year, the company turns out to be overvalued.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+9.48% | 33.62B | - | ||
+2.97% | 75.12B | B | ||
-7.69% | 42.91B | A- | ||
+15.01% | 18.93B | B | ||
+10.51% | 11.67B | A- | ||
-21.77% | 10B | B | ||
-6.66% | 9.85B | - | ||
-4.13% | 8.77B | A- | ||
-2.34% | 8.53B | C- | ||
-13.07% | 5.64B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- DD Stock
- DDNB34 Stock
- Ratings DuPont de Nemours, Inc.